Morning all!

Bioventix ( Bioventix (LON:BVXP) ) – 3560p – £183m – PER 32

Results For The 12 Months To End June 2019 – Revenue up 6%, PBT up 1%, 2nd Interim Dividend of 43p (36p) and a Special Dividend of 47p (55p).

I have been calling this as too expensive since it was about half this price, I still think it’s too expensive but, it always seems to do well, mostly based on future potential of antibody projects.

D4t4 Solutions ( D4t4 Solutions (LON:D4T4) ) – 213p – £86m – PER 15

H1 Trading Update – In-line assuming usual H2 weighting.

Tempted here but looks perhaps fairly priced, will be keen to see how FY actuals are, as I do quite like this, but never like an H2 weighting, even if it is “usual”.

Mattioli Woods ( Mattioli Woods (LON:MTW) ) – 665p – £178m – PER 16

Trading Update For The 12 Months To End September 2019 – In-line.

I reckon this is not going to move much higher until there’s some announcement regarding the use of the Net Cash.

Oxford Metrics ( Oxford Metrics (LON:OMG) ) – 92p – £115m – PER 25

Trading Update For The 12 Months To End September 2019 – Revenue to be in-line with PBT to be broadly in-line, Net Cash at £13.8m (£12.2m).

I reckon this is probably fairly priced around this level.

Trifast ( Trifast (LON:TRI) ) – 193p – £235m – PER 13

Trading Update For The 6 Months To End September 2019 – Markets remain challenging, expecting FY Underlying PBT of £22m (this looks like a 10% or so miss to me).

Is this factored into the price at present? Perhaps it is but, anyway, there’s not enough here to interest me further at the moment.

As always, all comment most welcome!

Unlock the rest of this article with a 14 day trial

or Unlock with your email

Already have an account?
Login here